High materiality7/10
Biogen (BIIB) Reiterated at Buy by Stifel After Investor Meeting
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BIIB target raised to $242; current price $214.77.
- BIIB target $242; price $214.77.
Key facts
- 01
Target: $242
- 02
Posted price: $214.77
- 03
Analyst firm: Stifel Nicolaus
- 04
Analyst: Paul Matteis
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.